The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2017 | What’s next for Richter’s syndrome?
Barbara Eichhorst
• 27 Mar 2017
Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, discusses the challenges of treating Richter’s syndrome at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. She highlights the need for clinical trials in this disease despite the small number of patients, and speaks about drug types which may be effective in this patient group.
